CVS Health Common Stock increased by 0.5% to $50.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.7%, from $49.84B to $50.68B. Over 5 years (FY 2020 to FY 2025), Common Stock shows relatively stable performance with a 1.6% CAGR.
An increase typically signals equity financing activities such as secondary offerings or stock-based compensation issuance. A decrease may indicate share repurchases or capital restructuring.
This represents the aggregate value of common stock at par value plus the additional paid-in capital received from share...
This is a standard line item across all public companies, representing the primary equity funding source for operations and growth.
equity_common_stocks_including_additional_paid_in_capital| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.00B | $47.13B | $47.38B | $47.68B | $47.87B | $48.05B | $48.19B | $48.31B | $48.65B | $48.83B | $48.99B | $49.21B | $49.37B | $49.51B | $49.66B | $49.84B | $50.02B | $50.18B | $50.40B | $50.68B |
| QoQ Change | — | +0.3% | +0.5% | +0.6% | +0.4% | +0.4% | +0.3% | +0.2% | +0.7% | +0.4% | +0.3% | +0.4% | +0.3% | +0.3% | +0.3% | +0.4% | +0.4% | +0.3% | +0.4% | +0.5% |
| YoY Change | — | — | — | — | +1.9% | +1.9% | +1.7% | +1.3% | +1.6% | +1.6% | +1.7% | +1.9% | +1.5% | +1.4% | +1.4% | +1.3% | +1.3% | +1.4% | +1.5% | +1.7% |